PT77168B - Process for the preparation of ergot alkaloids - Google Patents

Process for the preparation of ergot alkaloids

Info

Publication number
PT77168B
PT77168B PT77168A PT7716883A PT77168B PT 77168 B PT77168 B PT 77168B PT 77168 A PT77168 A PT 77168A PT 7716883 A PT7716883 A PT 7716883A PT 77168 B PT77168 B PT 77168B
Authority
PT
Portugal
Prior art keywords
preparation
ergot alkaloids
ergot
alkaloids
Prior art date
Application number
PT77168A
Other languages
Portuguese (pt)
Other versions
PT77168A (en
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Sa filed Critical Sandoz Sa
Publication of PT77168A publication Critical patent/PT77168A/en
Publication of PT77168B publication Critical patent/PT77168B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
PT77168A 1982-08-09 1983-08-08 Process for the preparation of ergot alkaloids PT77168B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH4772/82A CH649998A5 (en) 1982-08-09 1982-08-09 ERGOL DERIVATIVES, A METHOD FOR THEIR PRODUCTION AND HEALING AGENTS, CONTAINING THESE ERGOL DERIVATIVES AS AN ACTIVE SUBSTANCE.

Publications (2)

Publication Number Publication Date
PT77168A PT77168A (en) 1983-09-01
PT77168B true PT77168B (en) 1986-03-27

Family

ID=4282273

Family Applications (1)

Application Number Title Priority Date Filing Date
PT77168A PT77168B (en) 1982-08-09 1983-08-08 Process for the preparation of ergot alkaloids

Country Status (23)

Country Link
JP (1) JPS5948480A (en)
AT (1) AT383125B (en)
AU (1) AU563736B2 (en)
BE (1) BE897473A (en)
CA (1) CA1215972A (en)
CH (1) CH649998A5 (en)
DE (1) DE3327705A1 (en)
DK (1) DK361983A (en)
ES (1) ES8502992A1 (en)
FI (1) FI73679C (en)
FR (1) FR2531433B1 (en)
GB (1) GB2125041B (en)
GR (1) GR78923B (en)
HU (1) HU187600B (en)
IL (1) IL69450A (en)
IT (1) IT1168961B (en)
MY (1) MY8700166A (en)
NL (1) NL8302776A (en)
NZ (1) NZ205181A (en)
PH (1) PH20385A (en)
PT (1) PT77168B (en)
SE (1) SE8304315L (en)
ZA (1) ZA835850B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675322A (en) * 1984-12-10 1987-06-23 Eli Lilly And Company 1-Substituted-6-n-propyl-8β-methylthio-methylergolines
HU193782B (en) * 1985-06-21 1987-11-30 Richter Gedeon Vegyeszet Process for producing 2-halogeno-nicergoline derivatives and acid additional salts thereof
FR2589734B1 (en) * 1985-11-13 1988-09-02 Roussel Uclaf USE OF ERGOLIN DERIVATIVES FOR OBTAINING A GERIATRIC MEDICINE
US4798834A (en) * 1987-08-31 1989-01-17 Eli Lilly And Company Optionally substituted (3β-9,10-didehydro-2,3-dihydro ergoline as serotonergic function enhancement
DE3913756A1 (en) * 1989-04-21 1990-10-25 Schering Ag 8 (BETA) SUBSTITUTED ERGOLINE, METHOD FOR THE PRODUCTION AND USE THEREOF
DE10212564B4 (en) * 2002-03-12 2007-04-19 Neurobiotec Gmbh 1-Allyl ergot alkaloid derivatives and their use for the prophylaxis and treatment of migraine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE41533B1 (en) * 1974-03-14 1980-01-30 Sandoz Ltd Thiomethyl ergolene derivatives
US3901894A (en) * 1974-06-06 1975-08-26 Lilly Co Eli 8-thiomethylergolines
US3959288A (en) * 1974-12-13 1976-05-25 Eli Lilly And Company 8-Oxymethylergolines and process therefor
US4166182A (en) * 1978-02-08 1979-08-28 Eli Lilly And Company 6-n-propyl-8-methoxymethyl or methylmercaptomethylergolines and related compounds
US4382940A (en) * 1979-12-06 1983-05-10 Farmitalia Carlo Erba S.P.A. Ercoline derivatives and therapeutic compositions having CNS affecting activity

Also Published As

Publication number Publication date
FR2531433B1 (en) 1985-10-18
SE8304315D0 (en) 1983-08-08
GB2125041B (en) 1986-04-23
DE3327705A1 (en) 1984-02-09
CA1215972A (en) 1986-12-30
ATA286383A (en) 1986-10-15
FI832789A0 (en) 1983-08-02
ES524815A0 (en) 1985-02-01
IT1168961B (en) 1987-05-20
FI73679B (en) 1987-07-31
PH20385A (en) 1986-12-08
HU187600B (en) 1986-01-28
MY8700166A (en) 1987-12-31
ZA835850B (en) 1985-03-27
AT383125B (en) 1987-05-25
IL69450A0 (en) 1983-11-30
CH649998A5 (en) 1985-06-28
FR2531433A1 (en) 1984-02-10
IL69450A (en) 1986-10-31
DK361983D0 (en) 1983-08-08
ES8502992A1 (en) 1985-02-01
SE8304315L (en) 1984-02-10
NZ205181A (en) 1986-07-11
IT8322490A0 (en) 1983-08-09
PT77168A (en) 1983-09-01
JPS5948480A (en) 1984-03-19
GB2125041A (en) 1984-02-29
GR78923B (en) 1984-10-02
AU563736B2 (en) 1987-07-23
NL8302776A (en) 1984-03-01
DK361983A (en) 1984-02-10
FI73679C (en) 1987-11-09
AU1767283A (en) 1984-02-16
FI832789A (en) 1984-02-10
BE897473A (en) 1984-02-06
GB8321222D0 (en) 1983-09-07

Similar Documents

Publication Publication Date Title
DE3368047D1 (en) Process for the preparation of p-nitrosodiphenylamine
CY1470A (en) Process for the preparation of phenylalkylaminoethylsalicylamide
DE3377061D1 (en) Process for the preparation of 1-sulfo-2-oxoazetidine derivatives
PT78496B (en) Process for the preparation of ergoline derivatives
PT77168B (en) Process for the preparation of ergot alkaloids
PT76598B (en) Process for the preparation of pleuromutyline derivatives
PT76175A (en) Process for the preparation of benzothienyl-dialkylallylamines
PT74468B (en) Process for the preparation of ergoline derivatives
DE3362429D1 (en) Process for the preparation of thiadiazoloxyacetamides
DE3372479D1 (en) Process for the preparation of 4-chloro-2-nitrobenzonitrile
DE3367912D1 (en) Process for the preparation of n-allyl-o-alkyl-thioncarbamates
DE3361356D1 (en) Process for the preparation of 3-acylaminoanilines
DE3360384D1 (en) Process for the preparation of 1-hydroxyketones
GB2071651B (en) Fermentation process for the preparation of ergot alkaloids
GB8303475D0 (en) Ergot alkaloids
DE3365382D1 (en) Process for the preparation of 2-chlorobenzoxazols
PT77756A (en) Process for the preparation of pyridone derivatives
PL240608A1 (en) Process for preparing alkaloids of ergot
YU52982A (en) Process for preparing ergot alkaloids
GB2031890B (en) Process for the preparation of brominated ergot alkaloids
DE3365483D1 (en) Process for the preparation of 2-alkylthiomethyl-4-hydroxy-pyrimidines
DE3369844D1 (en) Process for the preparation of 2-imidazolines
GB2120245B (en) Process for the preparation of 3-hydroxy-benzo-diazepinones
PL246230A1 (en) Process for preparing ergot alkaloids
ZA83955B (en) Ergot alkaloids